Chevy Chase Trust’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-12,239
| Closed | -$215K | – | 697 |
|
2017
Q3 | $215K | Buy |
12,239
+5,497
| +82% | +$96.6K | ﹤0.01% | 642 |
|
2017
Q2 | $224K | Buy |
6,742
+469
| +7% | +$15.6K | ﹤0.01% | 631 |
|
2017
Q1 | $201K | Buy |
6,273
+207
| +3% | +$6.63K | ﹤0.01% | 636 |
|
2016
Q4 | $220K | Sell |
6,066
-2,933
| -33% | -$106K | ﹤0.01% | 635 |
|
2016
Q3 | $414K | Sell |
8,999
-43,073
| -83% | -$1.98M | ﹤0.01% | 584 |
|
2016
Q2 | $2.62M | Sell |
52,072
-9,299
| -15% | -$467K | 0.01% | 526 |
|
2016
Q1 | $3.28M | Sell |
61,371
-3,929
| -6% | -$210K | 0.02% | 511 |
|
2015
Q4 | $4.29M | Sell |
65,300
-5,351
| -8% | -$351K | 0.03% | 493 |
|
2015
Q3 | $3.99M | Sell |
70,651
-15,162
| -18% | -$856K | 0.02% | 492 |
|
2015
Q2 | $5.07M | Sell |
85,813
-10,294
| -11% | -$608K | 0.03% | 479 |
|
2015
Q1 | $5.99M | Sell |
96,107
-30,055
| -24% | -$1.87M | 0.04% | 467 |
|
2014
Q4 | $7.26M | Sell |
126,162
-10,860
| -8% | -$625K | 0.05% | 414 |
|
2014
Q3 | $7.37M | Sell |
137,022
-598
| -0.4% | -$32.1K | 0.05% | 402 |
|
2014
Q2 | $7.21M | Sell |
137,620
-7,672
| -5% | -$402K | 0.05% | 394 |
|
2014
Q1 | $7.68M | Sell |
145,292
-3,667
| -2% | -$194K | 0.06% | 368 |
|
2013
Q4 | $5.97M | Buy |
148,959
+25,781
| +21% | +$1.03M | 0.04% | 421 |
|
2013
Q3 | $4.65M | Buy |
123,178
+53,127
| +76% | +$2.01M | 0.04% | 452 |
|
2013
Q2 | $2.75M | Buy |
+70,051
| New | +$2.75M | 0.02% | 503 |
|